Cosmos Health 採用策略將比特幣和以太坊納入其國庫儲備資產

伊利諾州芝加哥 / ACCESSWIRE / 2024 年 11 月 18 日 / Cosmos Health Inc.（「Cosmos Health」或「公司」）（NASDAQ：COSM）是一家多元化、垂直整合的公司

CHICAGO, IL / ACCESSWIRE / November 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has adopted a strategy to include Bitcoin and Ethereum as part of its treasury reserve assets.

伊利諾州芝加哥/ ACCESSWIRE / 2024 年11 月18 日/ Cosmos Health Inc.（「Cosmos Health」或「公司」）（NASDAQ：COSM）是一家多元化、垂直整合的全球醫療保健集團，從事創新研發，擁有專有藥品和營養保健品品牌、醫療保健產品製造商和分銷商以及遠距醫療平台營運商今天宣布，已採取一項策略，將比特幣和以太坊納入其國庫儲備資產的一部分。

"Cosmos is a flexible, agile, and forward-looking Company. We believe this strategy will help us stand out by making a significant investment in the new era. Alongside our AI capabilities, we are now incorporating crypto assets and continually seeking additional future-focused investments to benefit our shareholders," said Greg Siokas, CEO of Cosmos Health. "We view select crypto assets, such as Bitcoin and Ethereum, not only as potential hedges against inflation and currency devaluation but also as diversification tools offering substantial upside potential. Accordingly, we look forward to building a sizable reserve in these assets."

「Cosmos 是一家靈活、敏捷且具有前瞻性的公司。我們相信，這項策略將幫助我們在新時代進行重大投資，從而脫穎而出。除了我們的人工智慧能力之外，我們現在正在整合加密資產，並不斷尋求更多的未來——集中投資使我們的股東受益。 「我們認為比特幣和以太坊等精選加密資產不僅是對抗通貨膨脹和貨幣貶值的潛在對沖工具，而且也是提供巨大上漲潛力的多元化工具。因此，我們期待在這些資產中建立相當大的儲備。

About Cosmos Health Inc.

關於宇宙健康公司

Cosmos Health Inc. (NASDAQ:COSM) is a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform. Cosmos Health's mission is to create a healthier world by delivering exceptional healthcare products and services to patients around the globe. The Company manufactures, markets, and sells a broad range of pharmaceutical and nutraceutical products through its wholly owned subsidiaries Cana Laboratories, Inc., Sky Premium Life, Inc., and Zip Doctor, Inc. Cosmos Health also operates a telehealth platform that provides convenient and affordable medical care to patients in the United States. For more information, please visit the Company's websites at www.cosmoshealthinc.com, www.skypremiumlife.com, www.cana.gr, www.zipdoctor.co, as well as LinkedIn and X.

Cosmos Health Inc.（納斯達克股票代碼：COSM）是一家多元化、垂直一體化的全球醫療保健集團，從事創新研發、專有藥品和營養保健品牌的所有者、醫療保健產品的製造商和分銷商以及遠距醫療平台的營運商。 Cosmos Health 的使命是透過為全球患者提供卓越的醫療保健產品和服務來創造一個更健康的世界。該公司透過其全資子公司Cana Laboratories, Inc.、Sky Premium Life, Inc. 和Zip Doctor, Inc. 製造、行銷和銷售廣泛的藥品和營養保健產品。提供便利的醫療服務。欲了解更多信息，請訪問公司網站 www.cosmoshealthinc.com、www.skypremiumlife.com、www.cana.gr、www.zipdoctor.co 以及 LinkedIn 和 X。

Forward-Looking Statements

前瞻性陳述

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to risks and uncertainties. Forward-looking statements are statements that are not historical facts and are generally, but not always, accompanied by words such as "anticipates," "believes," "continues," "could," "estimates," "expects," "forecasts," "intends," "may," "plans," "projects," "seeks," "strives," "will," or the negative of these terms or other comparable terminology. Forward-looking statements in this press release include, but are not limited to, statements regarding the Company's intention to include Bitcoin and Ethereum in its treasury reserve assets, the potential benefits of this strategy, and the Company's future-focused investments. These forward-looking statements are based on the Company's current beliefs, assumptions, and expectations and are not a guarantee of performance. Actual results could differ materially from those contained in any forward-looking statement. Factors that could cause actual results to differ materially from those set forth in the forward-looking statements include, but are not limited to, the following: the Company's ability to obtain the necessary regulatory approvals for its products and services, the Company's ability to successfully launch and market its products and services, the Company's ability to maintain and grow its customer base, the Company's ability to manage its expenses and maintain profitability, the Company's ability to attract and retain qualified personnel, the Company's ability to maintain良好关系 with its suppliers and distributors, the Company's ability to comply with applicable laws and regulations, and the Company's ability to identify and complete future-focused investments. Cosmos Health undertakes no obligation to revise or update any forward-looking statements as a result of new information, except as required by applicable law. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they were made. For a more complete discussion of factors that may affect the Company's future performance, please refer to the Company's filings with the Securities and Exchange Commission, which are available at www.sec.gov.

本新聞稿可能包含經修訂的 1933 年證券法第 27A 條和經修訂的 1934 年證券交易法第 21E 條含義內的前瞻性陳述，這些陳述存在風險和不確定性。前瞻性陳述是非歷史事實的陳述，通常但並非總是伴隨著“預期”、“相信”、“繼續”、“可能”、“估計”、“預期”、“預測”等詞語”、“打算” 、「可能」、「計劃」、「項目」、「尋求」、「努力」、「將」或這些術語或其他類似術語的否定形式。本新聞稿中的前瞻性陳述包括但不限於有關公司將比特幣和以太坊納入其國庫儲備資產的意圖、該策略的潛在好處以及公司面向未來的投資的陳述。這些前瞻性陳述是基於公司目前的信念、假設和期望，並非業績保證。實際結果可能與任何前瞻性聲明中包含的結果有重大差異。可能導致實際結果與前瞻性陳述中所述結果存在重大差異的因素包括但不限於：公司為其產品和服務獲得必要監管批准的能力、公司成功實現推出和營銷其產品和服務、公司維持和發展客戶群的能力、公司管理費用和維持盈利能力的能力、公司吸引和留住合格人才的能力、公司與供應商保持良好關係的能力和分銷商、公司遵守適用法律和法規的能力，以及公司識別和完成面向未來的投資的能力。 Cosmos Health 不承擔因新資訊而修改或更新任何前瞻性聲明的義務，除非適用法律要求。投資人應注意不要過度依賴這些前瞻性陳述，這些陳述僅代表發布當日的情況。有關可能影響公司未來業績的因素的更完整討論，請參閱本公司向美國證券交易委員會提交的文件（可在 www.sec.gov 上取得）。